liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Nitric oxide originating from NOS1 controls oxygen utilization and electrolyte transport efficiency in the diabetic kidney
Uppsala universitet, Integrativ Fysiologi.
Uppsala universitet, Integrativ Fysiologi.
Uppsala universitet, Integrativ Fysiologi.
Uppsala universitet, Integrativ Fysiologi.
2010 (engelsk)Inngår i: American Journal of Physiology - Renal Physiology, ISSN 0363-6127, E-ISSN 1522-1466, Vol. 298, nr 2, s. F416-F420Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Palm F, Fasching A, Hansell P, K llskog. Nitric oxide originating from NOS1 controls oxygen utilization and electrolyte transport efficiency in the diabetic kidney. Am J Physiol Renal Physiol 298: F416-F420, 2010. First published November 18, 2009; doi: 10.1152/ajprenal.00229.2009.-Nitric oxide (NO) is a potent regulator of both vascular tone and cellular oxygen consumption (QO(2)). Diabetic kidneys have reduced NO availability and increased QO(2). However, the exact nitric oxide synthase (NOS) isoform regulating QO(2), hemodynamics, and excretory function in the diabetic kidney remains unclear. We therefore investigated the effects of both selective neuronal NOS (NOS1) inhibition and nonselective NOS inhibition. Oxygen utilization, electrolyte transport efficiency [tubular Na+ transport (T-Na)/QO(2)], renal blood flow (RBF), glomerular filtration rate (GFR), and mean arterial pressure (MAP) were measured in vivo in control and streptozotocin-diabetic rats before and after administration of the selective NOS1 inhibitor S-methyl-L-thiocitrulline (SMTC) or the nonselective NOS inhibitor N-G-nitro-L-arginine methyl ester (L-NAME). Diabetic rats had higher baseline QO(2) and GFR than control rats, although RBF was similar in the groups. SMTC and L-NAME increased QO(2) and reduced T-Na/QO(2) only in the diabetic animals, whereas both inhibitors increased MAP and reduced RBF in both groups. GFR was reduced by L-NAME, but SMTC had no effect in either group. Carbachol increased RBF and decreased MAP in SMTC-treated rats, whereas it had no effect in L-NAME-treated rats, indicating that SMTC selectively inhibited NOS1. In conclusion, NO regulates RBF and GFR similarly in both control and diabetic rats. However, selective NOS1 inhibition increased QO(2) and reduced T-Na/QO(2) in the diabetic rat kidney, indicating a pivotal role of NO produced by NOS1 in maintaining control of QO(2) and tissue oxygenation in these kidneys.

sted, utgiver, år, opplag, sider
2010. Vol. 298, nr 2, s. F416-F420
Emneord [en]
diabetes, blood flow, oxygen consumption
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-99320DOI: 10.1152/ajprenal.00229.2009ISI: 000273984600020OAI: oai:DiVA.org:liu-99320DiVA, id: diva2:657175
Tilgjengelig fra: 2010-12-15 Laget: 2013-10-15 Sist oppdatert: 2017-12-06

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekst

Personposter BETA

Palm, Fredrik

Søk i DiVA

Av forfatter/redaktør
Palm, Fredrik
I samme tidsskrift
American Journal of Physiology - Renal Physiology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 27 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf